Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,557 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $492.17 | 29 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $348.92 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $337.51 | 19 | $0 (2024) |
| Axsome Therapeutics, Inc. | $304.19 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $215.51 | 12 | $0 (2024) |
| Corium, LLC | $197.37 | 11 | $0 (2024) |
| Alkermes, Inc. | $84.30 | 5 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $69.63 | 4 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $68.20 | 5 | $0 (2021) |
| Tris Pharma Inc | $61.82 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $933.61 | 49 | ABBVIE INC. ($216.22) |
| 2023 | $1,029 | 58 | ABBVIE INC. ($243.12) |
| 2022 | $233.88 | 13 | Supernus Pharmaceuticals, Inc. ($69.63) |
| 2021 | $360.92 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($131.97) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: OUD | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/07/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $19.98 | General |
| 08/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Neuroscience | ||||||
| 07/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Central Nervous System | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 581 | 1,757 | $408,550 | $102,156 |
| 2022 | 13 | 624 | 1,513 | $292,425 | $88,533 |
| 2021 | 7 | 358 | 708 | $98,600 | $43,326 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 122 | 354 | $132,750 | $34,599 | 26.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 164 | 583 | $87,450 | $21,948 | 25.1% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 32 | 149 | $52,150 | $14,262 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 206 | $56,650 | $12,742 | 22.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 49 | 277 | $41,550 | $10,763 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $8,700 | $3,130 | 36.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 31 | 77 | $15,400 | $3,095 | 20.1% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 37 | 66 | $9,900 | $1,000 | 10.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 16 | $4,000 | $616.49 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 398 | $109,125 | $30,002 | 27.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 152 | 444 | $64,500 | $18,387 | 28.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 251 | $37,650 | $11,573 | 30.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 148 | $22,200 | $9,757 | 43.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 44 | $8,800 | $5,408 | 61.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 42 | 49 | $10,600 | $3,318 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $7,500 | $3,155 | 42.1% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 29 | 30 | $7,500 | $1,628 | 21.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 19 | 19 | $5,700 | $1,396 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 30 | $4,550 | $1,003 | 22.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 11 | 17 | $4,250 | $984.95 | 23.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 20 | 24 | $4,800 | $973.75 | 20.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 25 | 34 | $5,250 | $946.93 | 18.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 68 | 167 | $25,050 | $11,125 | 44.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 69 | 180 | $18,000 | $8,345 | 46.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 120 | $18,000 | $6,605 | 36.7% |
About Edward Tucker, CRNP
Edward Tucker, CRNP is a Psychiatric/Mental Health healthcare provider based in Gardendale, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1619584505.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward Tucker, CRNP has received a total of $2,557 in payments from pharmaceutical and medical device companies, with $933.61 received in 2024. These payments were reported across 143 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,557).
As a Medicare-enrolled provider, Tucker has provided services to 1,563 Medicare beneficiaries, totaling 3,978 services with total Medicare billing of $234,016. Data is available for 3 years (2021–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Gardendale, AL
- Active Since 09/25/2020
- Last Updated 06/18/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1619584505
Products in Payments
- VRAYLAR (Drug) $492.17
- REXULTI (Drug) $347.45
- TRINTELLIX (Drug) $315.84
- Auvelity (Drug) $192.37
- Azstarys (Drug) $176.09
- AUSTEDO (Drug) $123.37
- Sunosi (Drug) $111.82
- CAPLYTA (Drug) $102.22
- Austedo XR (Drug) $92.14
- ARISTADA (Drug) $84.30
- QELBREE (Drug) $69.63
- SUNOSI (Drug) $68.20
- Dyanavel XR (Drug) $61.82
- SPRAVATO (Drug) $58.51
- SUBLOCADE (Drug) $46.28
- APLENZIN (Drug) $39.65
- ABILIFY MAINTENA (Drug) $33.62
- GRALISE (Drug) $31.00
- FANAPT (Drug) $27.42
- VYVANSE (Drug) $21.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.